LEARNING STRATEGY / 01
Medical Learning Platform
Know the guideline. Trust your next step.
Clinical guidance, flowcharts, drug tools, and learning resources—built around local treatment guidelines. One connected home for the knowledge you need, from your next exam to your next ward round.
✓
First 100 members get access before public launch. The library, clinical guidance, flowcharts, and drug tools stay free.
KNOWLEDGE, CONNECTED
STUDY LIBRARY
Infectious
Cardio
Endocrine
Clinical Guidelines
INFECTIOUS DISEASE
Severe malaria
Work through presentation, severity assessment, and guideline-based intravenous management.
RDT confirmed
Prostration present
IV access secured
LEARNING POINT
Sec. 4.2.1
Connect the presentation, assessment, and source in one learning view. Clinical content is pending review.
BOARDS RECALL
•
Active Review
Spaced review
64% mastery
The reference you need, arranged for the work.
From a condition to a dose to a referral decision, every module is anchored to the way care happens in practice — calm, structured, and instantly searchable.
Cardiovascular & Metabolic
•
NCD Protocols
Protocol preview
Hypertensive Emergency
Type 2 Diabetes / DKA
BP ≥ 180/120 mmHg
Target Organ Damage
Hypertensive Emergency (GHS STG Sec. 2.4.2)
Triage Mandate: Acute severe hypertension with encephalopathy, acute coronary syndrome, or renal impairment. Immediate controlled titration to prevent cerebral hypoperfusion.
Clinical review pending
Interface preview
RX
Dosing & Pharmacotherapy
Interface preview
Calculation controls will be enabled after clinical validation.
14 kg
Protocol review pending
3 kg
20 kg
50 kg
100 kg
CALCULATED DOSE
— mg stat
Clinical review pending
VOLUME
— mL
Clinical review pending
SAFETY
PREVIEW
Review pending
Not for clinical use
No verified calculation
A MOMENT OF ACTIVE LEARNING
Make the connection.
Then make it stick.
Try an original study-skills sample. Choose an answer to reveal the explanation.
THE FOUNDING CLINICAL COHORT
Be there from
the very beginning.
We're opening Wolo with a first cohort of 100 students and clinicians. Join the waitlist for early access and a voice in what we build next.
01 / Get in earlyExplore Wolo before the general community.
02 / Shape what comes nextTell us what would make study and practice easier.
03 / Keep knowledge freeThe library, clinical guidance, flowcharts, and drug tools stay free. Any paid feature will always be clearly identified.
100FIRST COHORT
YOUR PLACE AT THE START
Help build your next
clinical workspace.
A small first cohort. A platform for everyone.
Join the founding waitlist No payment details. No subscription required.Less scrolling. More clinical sense.
Move from presentation to action through connected decisions, not disconnected fragments of information. Explore how connected pathways can support clinical reasoning around national guidance.
WOLO / CLINICAL PATHWAYS /
Severe Preeclampsia & Eclampsia Protocol
Cardiovascular
Infectious / Malaria
Obstetric
Pathway interface preview
Try the interactive sample →
PRESENTATION
BP ≥ 160/110 mmHg + Proteinuria
≥ 20 wks gestation • Headache / epigastric pain
---->
↓
SEVERITY ASSESSMENT
Eclamptic Fits / Impending Signs Screen
Clonus, hyperreflexia, visual blur, severe RUQ pain
---->
↓
✓ Imminent Eclampsia / Severe Preeclampsia
STAT MgSO4
Magnesium Sulfate loading dose immediately
✕ Gestational HTN without Severe Features
Oral
Oral Labetalol / Close monitoring
GUIDELINE RATIONALE
GHS STG Sec. 18.2 / Obstetric Protocols
For severe preeclampsia or eclamptic convulsions, administer IV/IM Magnesium Sulphate regimen without delay before referral or delivery. Control BP with IV Hydralazine or oral Nifedipine; maintain target diastolic BP between 90–100 mmHg to preserve placental perfusion.
OUR EDITORIAL STANDARD
Trust starts with a visible source.
Clinical content is being prepared for review. Published material will identify its source, reviewer, and review date.
Traceable guidance
Source documents, editions, and relevant sections belong alongside the material they support.
Accountable publishing
Clinical review is pending. The interface preview is not an approved clinical reference.
A way to flag issues
A reporting channel for published content is planned before launch.
YOUR CLINICAL COMMUNITY
From study halls to ward rounds.
Medical students
Learn with context
Connect past questions with the underlying reference.
House officers
Make the connections
Bring your learning together across rotations.
Clinicians & educators
Share your perspective
Help shape reference material grounded in local practice.
BUILDING IN THE OPEN
A clear view of what's next.
Browse the experience
Browse the interface and try the learning sample.
Learn with the first 100
Early invitations and an opportunity to shape the platform. We will announce when the first cohort opens.
More ways to learn
The library, clinical guidance, flowcharts, and drug tools will be free. Offline access and additional capabilities are planned.
A few things worth knowing.
What will be free?
The Wolo library, clinical guidance, flowcharts, and drug tools will be free to access.
What does joining the first cohort mean?
The first 100 members will receive access before public launch and have an opportunity to give feedback. The broader waitlist stays open after the first cohort fills.
When will I get access?
We’ll send launch and invitation updates by email. A public launch date has not been announced.
How will paid features be identified?
Any paid feature will be clearly identified before you use it. Joining the waitlist doesn’t commit you to a purchase.
Better access to knowledge starts with us.
Join the founding waitlist for a library, clinical guidance, flowcharts, and drug tools built around local treatment guidelines. The first 100 members will be invited before public launch.
The library, clinical guidance, flowcharts, and drug tools stay free. Any paid feature will be clearly identified.